GIANNINI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.023
EU - Europa 5.341
AS - Asia 3.522
SA - Sud America 376
AF - Africa 100
OC - Oceania 79
Continente sconosciuto - Info sul continente non disponibili 18
Totale 19.459
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.876
RU - Federazione Russa 2.042
SG - Singapore 1.018
IT - Italia 961
HK - Hong Kong 716
CN - Cina 685
IE - Irlanda 527
SE - Svezia 451
PL - Polonia 422
VN - Vietnam 357
BR - Brasile 291
KR - Corea 278
DE - Germania 197
UA - Ucraina 187
FI - Finlandia 174
FR - Francia 160
GB - Regno Unito 116
TR - Turchia 110
IN - India 104
JP - Giappone 90
CA - Canada 86
AU - Australia 77
CI - Costa d'Avorio 42
BD - Bangladesh 34
AR - Argentina 29
NL - Olanda 21
CO - Colombia 20
MX - Messico 18
BE - Belgio 17
IQ - Iraq 17
AE - Emirati Arabi Uniti 14
ID - Indonesia 13
CH - Svizzera 12
JO - Giordania 12
EC - Ecuador 11
ES - Italia 11
NG - Nigeria 11
PK - Pakistan 11
ZA - Sudafrica 11
JM - Giamaica 10
VE - Venezuela 9
MY - Malesia 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AZ - Azerbaigian 7
MA - Marocco 7
CL - Cile 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
KE - Kenya 6
LT - Lituania 6
RO - Romania 6
EG - Egitto 5
PH - Filippine 5
SC - Seychelles 5
DZ - Algeria 4
EU - Europa 4
HN - Honduras 4
PR - Porto Rico 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
IL - Israele 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NO - Norvegia 3
PS - Palestinian Territory 3
PY - Paraguay 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BO - Bolivia 2
GD - Grenada 2
GR - Grecia 2
LB - Libano 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
SN - Senegal 2
TH - Thailandia 2
TW - Taiwan 2
VG - Isole Vergini Britanniche 2
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
Totale 19.433
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.254
Ashburn 761
Singapore 701
Fairfield 674
Hong Kong 590
San Jose 570
Chandler 543
Dublin 527
Warsaw 420
Cambridge 311
Seattle 305
Woodbridge 289
Seoul 278
Jacksonville 267
Wilmington 256
Beijing 241
Houston 240
Milan 211
The Dalles 190
Buffalo 177
Ann Arbor 161
Council Bluffs 156
Princeton 136
Los Angeles 117
Lauterbourg 111
Boardman 106
Boston 100
Ho Chi Minh City 100
Izmir 93
Altamura 91
Hanoi 90
Tokyo 90
Rome 84
Lawrence 80
Melbourne 76
Mumbai 72
Medford 63
Dallas 58
Hefei 48
New York 45
Bremen 43
Phoenix 43
Abidjan 42
Shanghai 42
San Diego 39
Munich 38
Florence 35
Moscow 35
Falls Church 26
Naples 25
Norwalk 25
Toronto 25
Chicago 24
São Paulo 24
Helsinki 23
Paris 23
Turin 23
Figino 21
Redondo Beach 21
Da Nang 19
Washington 19
Brooklyn 17
Brussels 17
Andover 16
Bologna 16
Orem 16
Atlanta 15
Hillsboro 15
Turku 15
Dearborn 13
Frankfurt am Main 13
Montreal 13
Palermo 13
London 12
Verona 12
Abuja 11
Auburn Hills 11
Bern 11
Columbus 11
Denver 11
Kent 11
Venice 11
Haiphong 10
Modena 10
San Francisco 10
Baghdad 9
Brasília 9
Guangzhou 9
Porto Alegre 9
Charlotte 8
Miano 8
Old Bridge 8
Philadelphia 8
Salerno 8
Stockholm 8
Tashkent 8
West Jordan 8
Bari 7
Cleveland 7
Detroit 7
Totale 12.728
Salva come PNG Salva come JPEG
Nome #
Hepatitis C Virus infection in the immunocompromised host: a complex scenario with variable clinical impact 339
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 324
HCV and lymphoproliferation 288
HCV Patients Psychopathology and Tryptophan Metabolism: Analysis of the Effects of Pegylated Interferon plus Ribavirin Treatment 268
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 232
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 220
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 216
Host genetic determinants in HCV-related mixed cryoglobulinemia 215
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 207
Host genetic determinants in HCV-related mixed cryoglobulinemia 202
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 197
Analysis of HCV persistence in patients with sustained virological response 197
Chronic hepatitis C and B-cell non-Hodgkin's lymphoma 195
Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment 195
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 195
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 190
Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia 187
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 186
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 185
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients 183
Interferon and thymosin combination therapy in naive patients with chronic hepatitis C. Preliminary results 183
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 182
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 181
Involvement of PI3K in HCV-related lymphoproliferative disorders 180
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 180
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 178
Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection 178
Host genetic determinants in HCV-related mixed cryoglobulinemia 175
HCV INFECTION OF PERIPHERAL AND LIVER MONONUCLEAR-CELLS - PATHOGENIC IMPLICATIONS 174
Tryptophan/kynurenine pathway changes in HCV-infected patients: possible involvement in associated neuropsychiatry pathology 174
Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection. 173
T(14;18) translocation in chronic hepatitis C virus infection 172
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 172
Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications 171
HBV and HCV chronic infection: Autoimmune manifestations and lymphoproliferation 171
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways. 170
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 169
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 166
Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways 162
Applicazione della metodica PCR (polymerase chain reaction) ed altre tecniche di biologia molecolare allo studio dell'infezione da virus C dell'epatite. 162
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role 161
A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector 160
The role of the rs12979860 polymorphism of the interleukin-28b as predictor of spontaneus clearance of HCV infection in patients with hemophilia 157
Hepatitis C virus core protein enhances B lymphocyte proliferation 156
HCV infection in mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma. 156
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 156
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 155
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 155
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 155
Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis 155
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 155
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 154
Tryptophan/Kynurenine pathway changes in HCV infected patients: possible involvment in associated neuropsychiathy pathology. 152
Effects of depletion of B cell by anti-CD20 monoclonal antibody in HCV+ mixed cryoglobulinemia (MC) and liver cirrhosis 151
ANALYSIS OF HCV INFECTION IN PATIENTS WITH B-CELL NON-HODGKINS-LYMPHOMA 151
Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis 150
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 147
HCV infection and carotid atherosclerosis: evidence in favour of a local viral action inside the plaque 146
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 145
Lack of preferential localization of tumoral mass in B-cell non-Hodgkin's lymphoma associated with hepatitis C virus infection 144
Hepatitis C virus lymphotropism and possible pathogenetic implications 144
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 144
Effect of antiviral treatment on the prevalence of BCL-2 recombination in HCV infected patients 144
The Hepatitis C Virus Infection as a Systemic Disease 142
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 142
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 142
Can depletion of B-cells by anti-CD20 monoclonal antibody in HCV plus mixed cryoglobulinemia (MC) improve liver cirrhosis? 141
Hepatitis C virus RNA localization in human carotid plaques. 140
Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis 137
Tryptophan/kynurenine Patway Changes in HCV-infected Patients: Possible Involvement In Associated Neuropsychiatry Pathology 137
Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases 137
Hepatitis C virus-related lymphoproliferative disorders: an overview 137
Characterization of uptake, degradation and toxicity of antisense ODNs in cancer cells. Characterization of uptake, degradation and toxicity of antisense ODNs in cancer cells 136
Hepatitis C virus as a lymphotropic agent: Evidence and pathogenetic implications 136
Mixed cryoglobulinemia syndrome is a negative prognostic factor in the standard of care (Peg-IFN+ribavirin) anti-HCV therapy 135
Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases 134
E' possibile la trasmissione del virus C dell'epatite nei centri di dialisi mediante il passaggio attraverso la membrana emodialitica? Risultati di uno studio preliminare 134
Hepatotropic viruses: new insights in pathogenesis and treatment 132
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 132
Hepatitis C virus lymphotrophism: lesson from a decade of studies 130
HCV infection in B-cell non-Hodgkin's lymphoma 130
Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes 129
Eventi Oncomolecolari nella Crioglobulinemia Mista 129
Hepatitis C virus biology. 128
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 128
Is t(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia? 127
Is T(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia? 126
HCV infection of mononuclear cells in chronic hepatitis and in mixed cryoglobulinaemia: possible pathogenetic implications. 126
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 126
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 125
Effect of rituximab on advanced liver disease in patients with HCV-related mixed cryoglobulinemia. 125
Hepatitis C virus infction of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. 123
Could HGV infection be implicated in lymphomagenesis? 122
Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx 122
Gene modulation associated with inhibition of liver regeneration in hepatitis B virus X transgenic mice. 120
HCV infection in B-cell non-Hodgkin’s lymphoma. 119
HCV infection in B-cell non-Hodgkin's lymphoma 119
Association between HCV infection and monoclonal gammopathy (MG): A putative role for genotype 2a? 117
HCV core protein induces B lymphocytes proliferation increasing DNP63 expression 116
Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues 115
Totale 16.183
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.758
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.758
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022730 0 0 0 43 29 18 24 54 35 12 198 317
2022/20232.211 224 230 99 184 230 459 325 103 244 22 59 32
2023/2024658 43 99 145 41 50 83 17 132 7 11 12 18
2024/20255.735 166 591 364 834 2.065 608 74 383 267 94 163 126
2025/20265.156 643 710 309 205 521 181 646 242 569 281 96 753
2026/20271.021 141 189 587 104 0 0 0 0 0 0 0 0
Totale 19.459